Elucidating the spectrum of α α-thalassemia mutations in Iran α α thalassemia (α α-thal) is one of the most common hemoglobin (Hb) disorders in the world. 1 α α-globin genes are located on chromosome 16. The majority of α α-thal mutations are deletions but point mutations are found as well. 2 Since the Iranian population is a mixture of different ethnic groups, frequency and distribution of α α-globin mutations in various regions of the country need to be clarified. These findings can contribute to a wider understanding of this disorder. Haematologica 2007; 92:992-993 This study included 653 individuals of different ethnic origins selected from patients referred to our center between January 1998 and February 2006. Subjects presented with low MCV (<85 fL), low MCH (<27dg), normal or slightly reduced hemoglobin (Hb) levels (<85g/dL), and normal HbA2 (<85dL).
A polymerase chain reaction (PCR) method introduced by Baysal and Huisman 3 was used to screen all samples for the two α-thal single gene deletions - Samples that showed no mutation with this method were further analyzed by DNA sequencing of the α-1 (Figure 1 ). Geographic distribution and frequency of the identified genotypes are presented in Table 1 and Figure 1 . The -α 3.7 mutation was the most frequent α-thalassemia mutation, contributing to 60.2% of α-thal alleles. Sixteen other α-globin mutations were found, nine of which (--MED, -α
) were present in frequencies above one percent, while seven mutations were found less frequently (Table  1) . No mutation was found using either PCR methods in 85 individuals studied after 2004. Further DNA sequencing of the α-1 and α-2 genes identified mutations in 47 patients. Since no DNA sequencing was performed before 2004, 67 of those patients remain unidentified. In total, 105 individuals (16.1%) had no identified α-globin mutation. We identified two novel mutations by sequence analysis: a single nucleotide mutation at the initiation codon of α gene (ATG-to-AGG) and a codon 99 mutation on α-1 gene (AAG-to-TAG), which is a stop codon. Iran, located in the Middle East between Iraq and Pakistan, has a population of 70 million. It is in the middle of the so-called Thalassemia Belt with a high thalassemia carrier rate. .
6,7
The 75% detection rate before 2004 increased to 90% after 2004 by means of Globin StripAssay and sequencing. The StripAssay is based on gap-PCR and covers the deletions analyzed in a recent review.
8 Gap-PCR detects large α-globin deletions and gene triplication, but cannot detect point mutations or small deletions/insertions. Although the 10% undetected patients is acceptable compared to other studies, sequencing both α genes could increase coverage. α-thalassemia disorder is characterized by a wide clinical and hematologic phenotypic heterogeneity. 8 Undetected cases could also be due to situations like antisense RNA transcription which was clarified in long-range analysis of chromosome structures.
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In a country like Iran, with a remarkable prevalence of αβ-globin mutations, the increased likelihood of co-inheritance of α-and β-thal may result in a large variety of phenotypes. 10 Our findings on the prevalence and distribution of α-globin mutations will provide a valuable basis for carrier screening, genetic counseling and prenatal diagnosis, helping the prevention of damaging forms of α-thal mutations.
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